Literature DB >> 33317052

Glycosaminoglycan Modification of Decorin Depends on MMP14 Activity and Regulates Collagen Assembly.

Alexes C Daquinag1, Zhanguo Gao1, Cale Fussell1, Kai Sun1, Mikhail G Kolonin1.   

Abstract

Proper processing of collagens COL1 and COL6 is required for normal function of adipose tissue and skeletal muscle. Proteoglycan decorin (DCN) regulates collagen fiber formation. The amino-terminus of DCN is modified with an O-linked glycosaminoglycan (GAG), the function of which has remained unclear. Previously, non-glycanated DCN (ngDCN) was identified as a marker of adipose stromal cells. Here, we identify MMP14 as the metalloprotease that cleaves DCN to generate ngDCN. We demonstrate that mice ubiquitously lacking DCN GAG (ngDCN mice) have reduced matrix rigidity, enlarged adipocytes, fragile skin, as well as skeletal muscle hypotrophy, fibrosis, and dysfunction. Our results indicate that DCN deglycanation results in reduced intracellular DCN-collagen binding and increased production of truncated COL6 chains, leading to aberrant procollagen processing and extracellular localization. This study reveals that the GAG of DCN functions to regulate collagen assembly in adipose tissue and skeletal muscle and uncovers a new mechanism of matrix dysfunction in obesity and aging.

Entities:  

Keywords:  adipose; collagen; decorin; glycosaminoglycan; matrix metalloprotease; muscle

Mesh:

Substances:

Year:  2020        PMID: 33317052      PMCID: PMC7764107          DOI: 10.3390/cells9122646

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  77 in total

Review 1.  Matrix metalloproteinases and the regulation of tissue remodelling.

Authors:  Andrea Page-McCaw; Andrew J Ewald; Zena Werb
Journal:  Nat Rev Mol Cell Biol       Date:  2007-03       Impact factor: 94.444

2.  Identification of functionally distinct fibro-inflammatory and adipogenic stromal subpopulations in visceral adipose tissue of adult mice.

Authors:  Chelsea Hepler; Bo Shan; Qianbin Zhang; Gervaise H Henry; Mengle Shao; Lavanya Vishvanath; Alexandra L Ghaben; Angela B Mobley; Douglas Strand; Gary C Hon; Rana K Gupta
Journal:  Elife       Date:  2018-09-28       Impact factor: 8.140

Review 3.  Impaired Adipogenesis and Dysfunctional Adipose Tissue in Human Hypertrophic Obesity.

Authors:  Ann Hammarstedt; Silvia Gogg; Shahram Hedjazifar; Annika Nerstedt; Ulf Smith
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

4.  Identification of substrate sequences for membrane type-1 matrix metalloproteinase using bacteriophage peptide display library.

Authors:  S Ohkubo; K Miyadera; Y Sugimoto; K Matsuo; K Wierzba; Y Yamada
Journal:  Biochem Biophys Res Commun       Date:  1999-12-20       Impact factor: 3.575

5.  Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility.

Authors:  K G Danielson; H Baribault; D F Holmes; H Graham; K E Kadler; R V Iozzo
Journal:  J Cell Biol       Date:  1997-02-10       Impact factor: 10.539

6.  Dichotomous effects of VEGF-A on adipose tissue dysfunction.

Authors:  Kai Sun; Ingrid Wernstedt Asterholm; Christine M Kusminski; Ana Carolina Bueno; Zhao V Wang; Jeffrey W Pollard; Rolf A Brekken; Philipp E Scherer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

7.  Genetic link between obesity and MMP14-dependent adipogenic collagen turnover.

Authors:  Tae-Hwa Chun; Mayumi Inoue; Hiroko Morisaki; Itaru Yamanaka; Yoshihiro Miyamoto; Tomonori Okamura; Kaori Sato-Kusubata; Stephen J Weiss
Journal:  Diabetes       Date:  2010-07-26       Impact factor: 9.461

Review 8.  Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment.

Authors:  Wen Zhang; Yan Ge; Qian Cheng; Qi Zhang; Lin Fang; Junnian Zheng
Journal:  Oncotarget       Date:  2018-01-03

9.  Non-glycanated Decorin Is a Drug Target on Human Adipose Stromal Cells.

Authors:  Alexes C Daquinag; Ali Dadbin; Brad Snyder; Xiaoping Wang; Aysegul A Sahin; Naoto T Ueno; Mikhail G Kolonin
Journal:  Mol Ther Oncolytics       Date:  2017-05-17       Impact factor: 7.200

10.  Impaired proteoglycan glycosylation, elevated TGF-β signaling, and abnormal osteoblast differentiation as the basis for bone fragility in a mouse model for gerodermia osteodysplastica.

Authors:  Wing Lee Chan; Magdalena Steiner; Tomasz Witkos; Johannes Egerer; Björn Busse; Shuji Mizumoto; Jan M Pestka; Haikuo Zhang; Ingrid Hausser; Layal Abo Khayal; Claus-Eric Ott; Mateusz Kolanczyk; Bettina Willie; Thorsten Schinke; Chiara Paganini; Antonio Rossi; Kazuyuki Sugahara; Michael Amling; Petra Knaus; Danny Chan; Martin Lowe; Stefan Mundlos; Uwe Kornak
Journal:  PLoS Genet       Date:  2018-03-21       Impact factor: 5.917

View more
  4 in total

Review 1.  Oncosuppressive roles of decorin through regulation of multiple receptors and diverse signaling pathways.

Authors:  Christopher Xie; Dipon K Mondal; Mikdat Ulas; Thomas Neill; Renato V Iozzo
Journal:  Am J Physiol Cell Physiol       Date:  2022-02-16       Impact factor: 4.249

2.  Novel regulatory roles of small leucine-rich proteoglycans in remodeling of the uterine cervix in pregnancy.

Authors:  Mariano Colon-Caraballo; Nicole Lee; Shanmugasundaram Nallasamy; Kristin Myers; David Hudson; Renato V Iozzo; Mala Mahendroo
Journal:  Matrix Biol       Date:  2021-12-01       Impact factor: 10.447

3.  Partial Ablation of Non-Myogenic Progenitor Cells as a Therapeutic Approach to Duchenne Muscular Dystrophy.

Authors:  Zhanguo Gao; Aiping Lu; Alexes C Daquinag; Yongmei Yu; Matthieu Huard; Chieh Tseng; Xueqin Gao; Johnny Huard; Mikhail G Kolonin
Journal:  Biomolecules       Date:  2021-10-15

4.  Single-Nucleus RNA Sequencing Reveals that Decorin Expression in the Amygdala Regulates Perineuronal Nets Expression and Fear Conditioning Response after Traumatic Brain Injury.

Authors:  Yingwu Shi; Xun Wu; Jinpeng Zhou; Wenxing Cui; Jin Wang; Qing Hu; Shenghao Zhang; Liying Han; Meixuan Zhou; Jianing Luo; Qiang Wang; Haixiao Liu; Dayun Feng; Shunnan Ge; Yan Qu
Journal:  Adv Sci (Weinh)       Date:  2022-01-17       Impact factor: 16.806

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.